Market Overview

Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest ROE

Share:

Below are the top drugs-generic stocks on the NASDAQ in terms of return on equity.

The trailing-twelve-month return on equity at Akorn (NASDAQ: AKRX) is 20.78%. Akorn's revenue for the same period is $304.28 million.

The trailing-twelve-month return on equity at Salix Pharmaceuticals (NASDAQ: SLXP) is 17.90%. Salix Pharma's operating margin for the same period is 26.47%.

The trailing-twelve-month return on equity at Mylan (NASDAQ: MYL) is 17.73%. Mylan's EPS for the same period is $1.52.

The trailing-twelve-month return on equity at Sagent Pharmaceuticals (NASDAQ: SGNT) is 16.09%. Sagent Pharma's profit margin for the same period is 12.09%.

Posted-In: Drugs-Generic Industry NASDAQ ROETrading Ideas

 

Related Articles (AKRX + MYL)

View Comments and Join the Discussion!
Lightning Fast
Market News Service
$199 Free 14 Day Trial
Book A Demo
Learn How You Can Succeed In The Market With Benzinga Pro

Fastest Market News

Real-Time News Alerts

Customizable News Filters

Book A Demo

Top 4 NYSE Stocks In The Aerospace/Defense Products & Services Industry With The Highest EPS

Top 4 Large-Cap Stocks In The Foreign Regional Banks Banks Industry With The Highest Revenue Estimates